The research company Pharmalundensis' rights issue was subscribed for SEK 2.14 million, corresponding to a subscription rate of 10.7 percent of the targeted issue size. This was stated in a press release. After issue costs of SEK 200,000, the company will receive SEK 1.94 million. All subscribers received the desired number of shares.The subscription price in the rights issue was SEK 0.50 per share, which is significantly higher than the share's last paid price of SEK 0.25.